Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Prednisolone and Alfacalcidol in Minimal Change Nephropathy
NCT03210688Phase 4Completed
- Sponsor
- Aarhus University
- Start
- May 2018
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alfacalcidol in minimal change disease (MCD), sponsored by Aarhus University. Started May 2018; status: completed.
02
Drugs
alfacalcidol
03
Conditions
minimal change disease (MCD)
Beyond the preview
Go deeper on NCT03210688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03210688.